Align Technology Inc - ALGN Short-Term Debt to Capital

ALGN (Align Technology, Inc.) - company brandmark

Dependence on costly RSUs and top engineers creates financial pressure, which is evident on the short-term debt-to-equity chart for Align Technology, Inc. (ALGN). The value of 0.01 determines the current status of the parameter. Business stability relies on proprietary digital platforms and manufacturing plants in Asia. However, a temporary decline in demand for aesthetics has constrained margins, increasing product storage costs.

ALGN - Invisalign Short-Term Debt to Equity Ratio over the range 07/04/2022 - 10/29/2026
Brand item of Align Technology

Global sales of aligners and scanners from Align Technology, Inc. (ALGN) ensure a steady cash flow, reducing reliance on local credit markets. This ratio compares the volume of liabilities with a maturity of up to one year against the amount of equity. By analyzing the trend of short-term loans relative to equity, an investor assesses liquidity risk and debt service costs. A decrease in this metric confirms financial autonomy and protects the business from sudden crises.

Main competitors

Short-Term Debt to Equity Boston Scientific Inc (BSX)|EW: Current Liabilities to Equity|Short-Term Debt to Capital RMD (ResMed Inc.)|insulet.com (PODD) - Current Liabilities to Capital|Zimmer Biomet Holdings - Short-Term Debt to Capital|The Cooper Companies, Inc. (COO) - Short-Term Debt to Equity Ratio|GMED: Short-Term Debt to Capital|TMDX - Short-Term Debt to Capital Coefficient|ATEC (Alphatec Holdings, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital artivion.com|Short-Term Debt to Equity Enovis (ENOV)|Short-Term Debt to Equity IART (Integra LifeSciences Corp)|Short-Term Debt to Capital ESTA (Motiva)|Short-Term Debt to Capital Coefficient iLet Bionic Pancreas (BBNX)|IRMD: Short-Term Debt to Equity Ratio|Current Liabilities to Equity EMBC|TNDM: Short-Term Debt to Capital|Current Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Short-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Short-Term Debt to Equity Ratio|Carlsmed Corp - Short-Term Debt to Capital|Current Liabilities to Capital RxSight Ophthalmic|CLPT: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Short-Term Debt to Capital|Sight Sciences Inc. (SGHT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital OBIO|Short-Term Debt to Equity Ratio anikatherapeutics.com ANIK|Short-Term Debt to Capital NSPR (InspireMD, Inc.)|Short-Term Debt to Capital Jin Medical International Ltd. ZJYL|VANI - Short-Term Debt to Equity|XTNT: Short-Term Debt to Equity|NMTC (NeuroOne Corp) - Short-Term Debt to Equity Ratio|Modular Medical, Inc. - Ratio of Short-Term Indebtedness to Capital|MYO (Myomo, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital envoymedical.com COCH|Short-Term Debt to Equity Vivos Therapeutics, Inc. (VVOS)|enVVeno Medical Corporation (NVNO) - Short-Term Indebtedness to Equity|Sintx Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Tenon Medical Inc TNON|ReWalk Robotics Ltd. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Autonomix Medical, Inc. AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Current Liabilities to Equity BBLG (Bone Biologics Corp.)|Short-Term Debt to Equity Axonics Modulation Technologies|Short-Term Debt to Equity Ratio Biolase Inc. (BIOL)|Short-Term Debt to Capital DYNT|FNA - Current Liabilities to Capital|Short-Term Debt to Equity INVO Bioscience INVO